scispace - formally typeset
R

Raghu Kalluri

Researcher at University of Texas MD Anderson Cancer Center

Publications -  325
Citations -  89851

Raghu Kalluri is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Angiogenesis. The author has an hindex of 115, co-authored 306 publications receiving 71127 citations. Previous affiliations of Raghu Kalluri include Beth Israel Deaconess Medical Center & Baylor College of Medicine.

Papers
More filters

A novel machine learning algorithm picks proteome signature to specifically identify cancer exosomes

Fernanda G. Kugeratski, +1 more
- 19 Jul 2023 - 
TL;DR: In this article , a novel machine learning-based computational method to distinguish cancers using a panel of proteins associated with exosomes is described. But, the method is not suitable for non-invasive early cancer diagnosis due to the low sensitivity and specificity of current diagnostic approaches.

Fibrogenesis & Tissue Repair

TL;DR: In most adult epithelia the process of replacing damaged or dead cells is maintained through the presence of stem/progenitor cells, which allow epithelial tissues to be repaired following injury as mentioned in this paper.

Mechanistic connection between inflammation and

Bong Lee, +1 more
TL;DR: Regardless of the underlying etiology, most forms of chronic kidney diseases are characterized by progressive fibrosis as a final common pathway that eventually affects all substructures of the kidney with the final consequence of end-stage renal disease.
Posted ContentDOI

Autophagy is associated with survival and resiliency of fibroblasts in long-term decaying post-mortem parenchymal tissue

TL;DR: Evidence is provided for the ability of normal fibroblasts to overcome extreme stress conditions and offers new insights into cell survival mechanisms and aging, with potential utility in tissue regeneration and repair.
Patent

Immuno-exosomes and methods of use thereof

TL;DR: In this paper, compositions comprising exosomes comprising an immunomodulatory molecule, e.g., ICOSL or OX40L, on their surface are presented for the treatment of diseases requiring immunOModulation, such as cancer, autoimmune disease, or infectious disease.